| PERIOD ENDING | 12-Sep-09 | 20-Jun-09 | 28-Mar-09 | 3-Jan-09 | | Total Revenue | 9,458,300 | 9,462,100 | 9,236,400 | 13,815,900 | | Cost of Revenue | 6,784,200 | 6,730,600 | 6,583,500 | 9,840,200 | | | Gross Profit | 2,674,100 | 2,731,500 | 2,652,900 | 3,975,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,396,000 | 2,373,900 | 2,371,400 | 3,362,800 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 278,100 | 357,600 | 281,500 | 612,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,500 | 3,300 | 1,200 | 3,300 | | Earnings Before Interest And Taxes | 279,600 | 360,900 | 282,700 | 616,200 | | Interest Expense | 78,300 | 77,200 | 78,200 | 112,500 | | Income Before Tax | 201,300 | 283,700 | 204,500 | 503,700 | | Income Tax Expense | 72,500 | 45,100 | 60,300 | 165,800 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 128,800 | 238,600 | 144,200 | 337,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 128,800 | 238,600 | 144,200 | 337,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $128,800 | $238,600 | $144,200 | $337,900 |
|
0.18% Nasdaq 
0.42%
Income Statement
